United States · Telehealth platform · Compounded
MEDVi review
A large membership service — it claims 500,000+ patients — that states the compounding caveat properly but publishes no price at all.
Overview
MEDVi sells GLP-1 treatment as part of a broader online practice covering weight loss, peptides and longevity, men’s health and women’s health, and says it has “500,000+ MEDVi patients”. The weight-loss offer is bundled: “Prescription to fast, effective GLP-1”, “1:1 physician guidance”, “Free dietician visits & care coaching included*”, “24/7 support” and “Fast & discreet shipping”.
It gets the disclosure right where many do not. The site states plainly that “Compound medications are dispensed by state-licensed pharmacies but are not FDA approved” — the sentence CoreAge Rx and Bliv both omit. It also describes an active pharmacy oversight process rather than a vague assurance: it works with “multiple USA certified pharmacies”, and says its team “meets regularly with pharmacies to discuss any product shortages, shipping delays, and get updated reports on their medication testing.”
What it does not publish is a price. We could find no monthly figure on any accessible page, which is why this entry has no entry price and scores poorly on disclosure. The asterisk on the free dietician visits leads to “subject to insurance and copays eligibility to be determined at time of visit”, so what is included depends on circumstances the site does not spell out. FDA issued a warning letter to MEDVi, LLC in February 2026, set out above.
Medications and supply
Compounded, and correctly disclosed: “Compound medications are dispensed by state-licensed pharmacies but are not FDA approved.” Multiple pharmacies are used rather than one, none is named, and no 503A or 503B status is given — though the described practice of collecting “updated reports on their medication testing” is more than most services claim to do.
- Compounded GLP-1 medication (semaglutide and tirzepatide are not individually specified on accessible pages)
How the service works
- Consultation
- “Prescriptions are issued only after an online consultation with an independent licensed provider.”
- Eligibility
- Not stated in the sources we checked.
- Provider involvement
- Independent licensed providers prescribe after consultation, with “1:1 physician guidance” included in the offer.
- Lab requirements
- Not stated in the sources we checked.
- Pharmacy fulfilment
- “Multiple USA certified pharmacies”, none named, with the company stating it meets them regularly over shortages, shipping delays and medication testing reports. No 503A or 503B designation.
- Shipping
- “Fast & discreet shipping”, with no stated timeframe.
- Support services
- 24/7 support, free dietician visits and care coaching — the last two marked “*Free to end users subject to insurance and copays eligibility to be determined at time of visit.”
What it costs
| Item | Published price | Notes |
|---|
- Membership fee
- Not stated in the sources we checked.
- Medication fee
- Not stated in the sources we checked.
- Insurance
- Insurance is referenced only in the footnote governing whether the dietician visits are free, not as a route to paying for medication.
- HSA / FSA
- Not stated in the sources we checked.
- Cancellation
- Not stated in the sources we checked.
- Refunds
- Not stated in the sources we checked.
Pros
- States the compounding caveat properly — that compounded medicines are not FDA approved — which several cheaper competitors do not.
- Describes concrete pharmacy oversight, including regular review of medication testing reports, rather than asserting quality.
- Dietician visits and care coaching are included in the offer rather than sold separately.
- 24/7 support and 1:1 physician guidance.
Cons
- An FDA warning letter to MEDVi, LLC in February 2026.
- No price published anywhere we could access, so the offer cannot be compared with anything.
- No cancellation or refund terms published.
- The individual medications are not named on accessible pages.
- The “free” dietician visits are conditional on insurance and copay eligibility determined at the visit.
Who it may suit
Hard to say, which is the finding. The disclosure quality and the pharmacy oversight are better than much of this tier, but a service that will not publish a price cannot be compared with one that will. Ask for the monthly cost and the cancellation terms before the consultation, not after.
Limitations
- We could not retrieve the FDA warning letter itself, only its existence, reference and date.
- No pricing page was reachable, so no cost figure could be verified at all.
- The specific medications, eligibility criteria, lab requirements, cancellation and refund terms are all unpublished.
Questions
How much does MEDVi cost?
It does not say. We could not find a monthly price on any accessible page, which is unusual for a service of this size and is the main reason it scores badly on our disclosure checklist. Ask before you book the consultation.
Is MEDVi’s medication FDA approved?
No, and to its credit the site says so: “Compound medications are dispensed by state-licensed pharmacies but are not FDA approved.” That is the disclosure the cheapest services in this tier tend to leave out.
Are the dietician visits really free?
Conditionally. The asterisk reads “Free to end users subject to insurance and copays eligibility to be determined at time of visit” — so whether you pay is decided at the appointment rather than stated up front.
Which pharmacy fills the prescription?
MEDVi uses “multiple USA certified pharmacies” and names none. It does describe meeting them regularly about shortages, delays and medication testing reports, which is more oversight than most services describe, but it is not the same as telling you who compounds your medicine.
Has MEDVi had an FDA warning letter?
Yes. FDA issued one to MEDVi, LLC dba MEDVi on 20 February 2026, reference MARCS-CMS 721455, in its enforcement against telehealth companies over compounded GLP-1 marketing. We could not retrieve the letter to see what it specifically cites.
Sources
Everything on this page traces to one of the links below, retrieved on the date shown. Prices and programme terms in this market change without notice — confirm against the provider before you buy.